LivaNova PLC (LIVN)

Market Cap	3.56B +85.2%
Revenue (ttm)	1.39B +10.7%
Net Income	-242.47M
EPS	-4.45
Shares Out	54.69M
PE Ratio	n/a
Forward PE	15.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	381,997
Open	65.19
Previous Close	65.18
Day's Range	64.24 - 65.61
52-Week Range	35.00 - 71.92
Beta	0.97
Analysts	Buy
Price Target	72.43 (+11.18%)
Earnings Date	May 6, 2026

About LIVN

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing sy...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 10, 1993
• Employees: 3,300
• Stock Exchange: NASDAQ
• Ticker Symbol: LIVN
• Website: https://www.livanova.com

Analyst Summary

According to 7 analysts, the average rating for LIVN stock is "Buy." The 12-month stock price target is $72.43, which is an increase of 11.18% from the latest price.

Price Target

$72.43

(11.18% upside)

Analyst Consensus: Buy